BACKGROUND: Human herpesvirus type 8 (HHV-8) is hyperendemic in Amerindian populations, but its modes of transmission are unknown. METHODS: Antibodies against either HHV-8 lytic antigen or HHV-8 latency-associated nuclear antigen (LANA) were detected, by immunofluorescence assays, in 339 Amerindians and 181 non-Amerindians from the Brazilian Amazon. Serological markers of oro-fecal (hepatitis A), parenteral (hepatitis B and C), and sexual (herpes simplex virus type 2 and syphilis) transmission were measured by specific ELISAs. Salivary HHV-8 DNA was detected by use of a nested polymerase chain reaction assay and was sequenced. RESULTS: Antibodies against either lytic antigen or LANA were detected in 79.1% of Amerindians and in 6.1% of non-Amerindians (adjusted seroprevalence ratio [SR], 12.63 [95% confidence interval {CI}, 7.1-22.4]; P<.0001). HHV-8 seroprevalence increased with age among Amerindians (P(Trend) < .001) and already had high prevalence in childhood but was not sex specific in either population. The 2 populations did not differ in seroprevalence of oro-fecal or parenteral markers, but seroprevalence of markers of sexual transmission was lower among Amerindians. HHV-8 DNA in saliva was detected in 47 (23.7%) of 198 HHV-8 seropositive Amerindians. Detection of HHV-8 DNA decreased with age (P(Trend) < .04) and was more common in men (SR, 2.14 [95% CI, 1.3-3.5]; P=.003). A total of 36 (76.6%) of the 47 saliva HHV-8 DNA samples were sequenced, and all clustered as subtype E. CONCLUSION: The data support the hypothesis of early acquisition and horizontal transmission, via saliva, of HHV-8 subtype E in Amerindian populations.
BACKGROUND:Humanherpesvirus type 8 (HHV-8) is hyperendemic in Amerindian populations, but its modes of transmission are unknown. METHODS: Antibodies against either HHV-8 lytic antigen or HHV-8 latency-associated nuclear antigen (LANA) were detected, by immunofluorescence assays, in 339 Amerindians and 181 non-Amerindians from the Brazilian Amazon. Serological markers of oro-fecal (hepatitis A), parenteral (hepatitis B and C), and sexual (herpes simplex virus type 2 and syphilis) transmission were measured by specific ELISAs. Salivary HHV-8 DNA was detected by use of a nested polymerase chain reaction assay and was sequenced. RESULTS: Antibodies against either lytic antigen or LANA were detected in 79.1% of Amerindians and in 6.1% of non-Amerindians (adjusted seroprevalence ratio [SR], 12.63 [95% confidence interval {CI}, 7.1-22.4]; P<.0001). HHV-8 seroprevalence increased with age among Amerindians (P(Trend) < .001) and already had high prevalence in childhood but was not sex specific in either population. The 2 populations did not differ in seroprevalence of oro-fecal or parenteral markers, but seroprevalence of markers of sexual transmission was lower among Amerindians. HHV-8 DNA in saliva was detected in 47 (23.7%) of 198 HHV-8 seropositive Amerindians. Detection of HHV-8 DNA decreased with age (P(Trend) < .04) and was more common in men (SR, 2.14 [95% CI, 1.3-3.5]; P=.003). A total of 36 (76.6%) of the 47 saliva HHV-8 DNA samples were sequenced, and all clustered as subtype E. CONCLUSION: The data support the hypothesis of early acquisition and horizontal transmission, via saliva, of HHV-8 subtype E in Amerindian populations.
Authors: G R Simpson; T F Schulz; D Whitby; P M Cook; C Boshoff; L Rainbow; M R Howard; S J Gao; R A Bohenzky; P Simmonds; C Lee; A de Ruiter; A Hatzakis; R S Tedder; I V Weller; R A Weiss; P S Moore Journal: Lancet Date: 1996-10-26 Impact factor: 79.321
Authors: S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore Journal: Nat Med Date: 1996-08 Impact factor: 53.440
Authors: J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey Journal: N Engl J Med Date: 2000-11-09 Impact factor: 91.245
Authors: Sam M Mbulaiteye; Ruth M Pfeiffer; Eric A Engels; Vickie Marshall; Paul M Bakaki; Anchilla M Owor; Christopher M Ndugwa; Edward Katongole-Mbidde; James J Goedert; Robert J Biggar; Denise Whitby Journal: J Infect Dis Date: 2004-09-10 Impact factor: 5.226
Authors: J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos Journal: Blood Date: 1995-08-15 Impact factor: 22.113
Authors: Landon N Olp; Danielle M Shea; Maxine K White; Clement Gondwe; Chipepo Kankasa; Charles Wood Journal: Int J Cancer Date: 2012-08-20 Impact factor: 7.396
Authors: Veenu Minhas; Kay L Crabtree; Ann Chao; Janet M Wojcicki; Adrian M Sifuniso; Catherine Nkonde; Chipepo Kankasa; Charles D Mitchell; Charles Wood Journal: Am J Epidemiol Date: 2011-03-28 Impact factor: 4.897
Authors: Sagar V Nadgir; Heather R Hensler; Emilee R Knowlton; Charles R Rinaldo; Giovanna Rappocciolo; Frank J Jenkins Journal: J Clin Microbiol Date: 2013-04-03 Impact factor: 5.948
Authors: Jaila D Borges; Vanda A U F Souza; Claudia Giambartolomei; Frank Dudbridge; Wilton S Freire; Shinai Arriel Gregório; Pasesa Pascuala Quispe Torrez; Mariana Quiroga; Philippe Mayaud; Claudio S Pannuti; Maria Cláudia Nascimento Journal: J Infect Dis Date: 2012-04-03 Impact factor: 5.226
Authors: Vivian Kourí; Pedro A Martínez; Orestes Blanco; Virginia Capó; María E Rodríguez; María Del C Dovigny; Lidia Cardellá; Angela Gala; Narciso A Jiménez; Consuelo Correa; Yoan Alemán; Lissette Pérez; Alina Álvarez; Ulrich Hengge Journal: Herpesviridae Date: 2010-12-07
Authors: Vanda A U F Souza; Francisco M Salzano; Maria Luiza Petzl-Erler; Maria Claudia Nascimento; Philippe Mayaud; Jaila Dias Borges; Claudio S Pannuti Journal: Emerg Infect Dis Date: 2010-06 Impact factor: 6.883